Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The upper airway dilator muscles are a group of skeletal muscles in the pharyngeal and oral region—including the genioglossus (the most important member), levator palatini, tensor palatini, geniohyoid, and stylopharyngeus—which contract to maintain airway openness, particularly during inspiration[2][3][6][7]. These muscles are vital for preventing airway collapse, especially during sleep, and are critically involved in the pathophysiology of obstructive sleep apnea when their activity is diminished[2][3][5][7]. Their contraction is coordinated via neural reflexes that respond rapidly to negative airway pressure, with the genioglossus muscle innervated primarily by the hypoglossal nerve[1][3]. While the upper airway dilator muscles are essential in respiratory physiology and sleep medicine, they do not represent a classical drug target such as a receptor or enzyme, being instead a functional and anatomical category[3][4][7].
Not applicable (these are anatomical and physiological structures, not molecular targets; interventions aim to increase muscle tone via neural or device-based approaches rather than direct "molecule-receptor" mechanisms)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Upper airway dilator muscle.